Batch of blood pressure capsules recalled after potential manufacturing error
In News
Follow this topic
Bookmark
Record learning outcomes
A batch of blood pressure capsules have been recalled by its manufacturer after what the Medicines and Healthcare products Regulatory Agency said was a "potential manufacturing error".
Crescent Pharma Limited issued the precautionary recall of a batch of Ramipril 10mg capsules over concerns some cartons contain blister strips of a lower dose.
The alert was raised after a patient complained that a blister pack of Ramipril 5mg capsules was found inside a sealed carton of Ramipril 10mg capsules.
"Both product batches were manufactured at the same manufacturing site, and the error appears to have occurred during secondary packaging of the cartons," the MHRA said, adding the risk to patients taking the lower dose "for a limited time" was "very low".
The MHRA's chief safety officer Dr Alison Cave advised patients who take Ramipril 10mg to check the packaging for batch number GR174091 which can be found on the outer carton with the expiry date information.
"If you have received this batch, check that the medication name on the carton matches the blister strips inside," she said, urging patients to contact their pharmacy if the 10mg carton of Ramipril contains blister strips labelled Ramipril 5mg capsules.
"If you have an impacted pack or previously received this batch and you believe you have taken any Ramipril 5mg capsules that were included in error and are currently experiencing any adverse effects, seek medical advice."